Reader Remarks on:

The ACCORD and ADVANCE Trials: Implications for Patients with Type 2 Diabetes

How to achieve intense glycaemic control

How to achieve intense glycaemic control

Bassem Zarif Fouad, National Heart Institute, Egypt, 23 May 2009 5:10 AM EST

Competing interests: None declared

I think that different hypoglycaemic agents used to achieve intense blood glucose control, were sure having different effects on ( macro- vascular )CV risk . And the concept that intense blood glucose control had no or worst outcome on CV risk, is something too early and may be very deleterious . we should include in the data analysis the agent(S) used to achieve intense glucose control and other risk factors control status in a multivariate analysis to get the proper evaluation of the effect of intense glucose on Macro-vascular complications .

Your Remark:

Reader Remarks are intended to encourage lively discussion of clinical topics with your peers in the medical community. Please consider this when composing your remark.

Remark subject:*

Your remark:*

Fields marked with an * are required.

Name as you'd like it to appear:
First & middle initial:*

Last:*

Email address (will not
be published):*

Place of work (optional):

Submitting a comment indicates you have read and agreed to the remark guidelines and declare:*

No competing interests

Or, the following competing interests (for example, financial stakes or professional relationships):

PRIVACY: We will not use your email address, submitted for a comment, for any other purpose nor sell, rent, or share your e-mail address with any third parties. Please see our Privacy Policy.

CLEAR erases anything you've added in any part of the form. CONTINUE allows you to check your entire post (and edit it if necessary) before submitting.

To ensure that your Reader Remark is not formatted as one long paragraph, precede new paragraphs with either a blank line or an indentation.

Search

Sign-In

Forgot your password?

New to Journal Watch?